Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology

Area of Science:

• Genetics
• Molecular Diagnostics
• Biochemistry

Background:

• Alpha-1-antitrypsin deficiency (AATD) is a rare genetic disorder caused by SERPINA1 gene mutations, leading to low alpha-1 antitrypsin (AAT) protein levels.
• Traditional AATD diagnosis involves AAT concentration, phenotyping (IEF), and genotyping (PCR), with sequencing in select cases.

Purpose of the Study:

• To develop and evaluate a novel diagnostic algorithm for AATD utilizing Luminex xMAP technology.
• To assess the efficiency and convenience of the new algorithm compared to traditional methods.

Main Methods:

• A new diagnostic algorithm based on Luminex xMAP technology was developed and validated.
• Two phases of testing were conducted: initial comparison with traditional methods (1979 samples) and validation of the new method alone (1133 samples).

Main Results:

• The Luminex xMAP algorithm identified 14 SERPINA1 gene mutations simultaneously, significantly expanding detection compared to the traditional two-mutation analysis.
• Nephelometric measurements and sequencing were reduced by 79% and 63.4%, respectively, while IEF assay volume remained constant.

Conclusions:

• The Luminex xMAP-based algorithm offers a convenient, fast, and user-friendly approach to AATD diagnosis.
• This new technology simplifies and accelerates the diagnostic workup for patients with suspected AATD.